News
Filter
-
Phosphate Therapeutics acquires novel phosphate binder (PT20) from the Medical Research Council and secures development funding from Inventages venture capital for compound’s phase 2 development
-
New drug discovery collaboration with University of Bristol launched
-
New cancer therapeutic antibody project launched
-
Aptuscan acquired by Avacta
-
MRC Technology to manage intellectual property for AICR
-
Crowd sourcing in drug discovery
-
The art of turning ideas into products
-
New Director of Corporate Partnerships appointed
-
MRC scientists redefine how our immune system responds to viruses
-
Scientists ‘give botox a facelift’ to improve use for Parkinson’s
-
1st patient treated with BAN2401
-
MRC People Exchange Programme
